ANTICOAGULANT selection has moved from a choice of one known option (warfarin) to now include widely used, and becoming more confidently prescribed, new oral anticoagulants (NOACs), apixaban, dabigatran and rivaroxaban.
The choice of anticoagulant depends on the characteristics of the patient and the medicine, says an article in the latest issue of NPS MedicineWise's Australian Prescriber.
Key considerations identified in the paper include patient adherence, kidney and liver function, and potential interactions with concomitant drugs.
The article has CPD points available for pharmacists.
CLICK HERE for details.
The above article was sent to subscribers in Pharmacy Daily's issue from 08 Dec 16
To see the full newsletter, see the embedded issue below or CLICK HERE to download Pharmacy Daily from 08 Dec 16